Sharma Aparna, Giorgakis Emmanouil
Department of Nephrology, University of Arkansas for Medical Sciences, Little Rock, AR 72223, United States.
Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72223, United States.
World J Transplant. 2022 Jul 18;12(7):157-162. doi: 10.5500/wjt.v12.i7.157.
The human gut microbiome refers to all of the microorganisms present throughout the length of the gastrointestinal tract. Gut flora influence host metabolic and immune processes in myriad ways. They also play an important role in maturation and modulation of the immune system. Dysbiosis or a pathologic alteration in gut flora has been implicated in a number of diseases ranging from metabolic, autoimmune and degenerative. Whether dysbiosis has similar implications in organ transplant has been the focus of a number of pre-clinical and clinical studies. Researchers have observed significant microbiome changes after solid organ transplantation in humans that have been associated with clinical outcomes such as post-transplant urinary tract infections and diarrhea. In this article, we will discuss the available data regarding pathologic alterations in gut microbiome (dysbiosis) in solid organ transplant recipients as well as some of challenges in this field. We will also discuss animal studies focusing on mouse models of transplantation that shed light on the underlying mechanisms that explain these findings.
人类肠道微生物群是指存在于整个胃肠道中的所有微生物。肠道菌群以多种方式影响宿主的代谢和免疫过程。它们在免疫系统的成熟和调节中也起着重要作用。肠道菌群失调或病理改变与许多疾病有关,包括代谢性、自身免疫性和退行性疾病。肠道菌群失调在器官移植中是否有类似影响一直是许多临床前和临床研究的重点。研究人员观察到,人类实体器官移植后微生物群发生了显著变化,这些变化与移植后尿路感染和腹泻等临床结果有关。在本文中,我们将讨论实体器官移植受者肠道微生物群病理改变(菌群失调)的现有数据,以及该领域的一些挑战。我们还将讨论以移植小鼠模型为重点的动物研究,这些研究揭示了解释这些发现的潜在机制。